INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,489,080 | +33.0% | 557,937 | +18.2% | 0.11% | +39.5% |
| Q2 2023 | $27,438,417 | -1.1% | 471,937 | +5.0% | 0.08% | -8.4% |
| Q1 2023 | $27,743,054 | +161.9% | 449,353 | +169.6% | 0.08% | +130.6% |
| Q4 2022 | $10,594,626 | -32.1% | 166,687 | -22.4% | 0.04% | -28.0% |
| Q3 2022 | $15,595,000 | -3.5% | 214,687 | -9.6% | 0.05% | -3.8% |
| Q2 2022 | $16,155,000 | +0.3% | 237,615 | +33.8% | 0.05% | +30.0% |
| Q1 2022 | $16,099,000 | +3.1% | 177,615 | +3.8% | 0.04% | +21.2% |
| Q4 2021 | $15,618,000 | +11.2% | 171,115 | -1.2% | 0.03% | +3.1% |
| Q3 2021 | $14,042,000 | +25.6% | 173,140 | +44.5% | 0.03% | +23.1% |
| Q2 2021 | $11,180,000 | -5.0% | 119,851 | +9.0% | 0.03% | -10.3% |
| Q1 2021 | $11,765,000 | +27.2% | 109,951 | +3.8% | 0.03% | +26.1% |
| Q4 2020 | $9,248,000 | +45.1% | 105,951 | +14.8% | 0.02% | +15.0% |
| Q3 2020 | $6,372,000 | +43.0% | 92,323 | +0.4% | 0.02% | +25.0% |
| Q2 2020 | $4,456,000 | – | 91,987 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |